Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / #OTHER
-
Shares outstanding
-
67M
-
Number of holders
-
95
-
Total 13F shares, excl. options
-
57.1M
-
Shares change
-
-642K
-
Total reported value, excl. options
-
$224M
-
Value change
-
-$3.07M
-
Put/Call ratio
-
5
-
Number of buys
-
51
-
Number of sells
-
-49
-
Price
-
$3.93
Significant Holders of Generation Bio Co. - #OTHER (GBIO) as of Q4 2022
119 filings reported holding GBIO - Generation Bio Co. - #OTHER as of Q4 2022.
Generation Bio Co. - #OTHER (GBIO) has 95 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 57.1M shares
of 67M outstanding shares and own 85.24% of the company stock.
Largest 10 shareholders include FMR LLC (8.91M shares), Atlas Venture Life Science Advisors, LLC (8.28M shares), PRICE T ROWE ASSOCIATES INC /MD/ (7.26M shares), BlackRock Inc. (3.71M shares), Bellevue Group AG (3.63M shares), T. Rowe Price Investment Management, Inc. (3.58M shares), PFM Health Sciences, LP (2.9M shares), Artal Group S.A. (2.81M shares), VANGUARD GROUP INC (2.23M shares), and FARALLON CAPITAL MANAGEMENT LLC (1.25M shares).
This table shows the top 95 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.